- Paris Isn’t the Only Clean Energy Pact the U.S. Is Fleeing
The White House’s deep proposed cuts to energy R&D could cede leadership to China, and derail the international Mission Innovation partnership.
- Promising New Cancer Drugs Won’t Go Far Unless Everyone Gets Genetic Testing
Loxo Oncology is developing a so-called “tumor agnostic” drug that requires expensive genetic testing often not covered by insurance.
Digest powered by RSS Digest